Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
07/16/2008 | EP1944034A1 Adsorbent for advanced glycation endproducts |
07/16/2008 | EP1944022A1 Pharmaceutical compositions combining analgesics and anticonvulsant agents for the treatment of chronic and acute pain |
07/16/2008 | EP1944019A2 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
07/16/2008 | EP1943244A1 Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitors |
07/16/2008 | EP1943241A1 Pyrazoles useful in the treatment of inflammation |
07/16/2008 | EP1943234A1 Triazole compounds as lipoxygenase inhibitors |
07/16/2008 | EP1943225A1 Pyrazoles useful in the treatment of inflammation |
07/16/2008 | EP1942936A2 Compositions and methods for treating inflammation |
07/16/2008 | EP1942925A2 Methods for fusion polypeptide delivery into a cell |
07/16/2008 | EP1942880A1 A combination of cannabinoids for the treatment of peripheral neurophatic pain |
07/16/2008 | EP1660093B1 Ammonium salts of ornithine derivatives for treating inflammatory diseases |
07/16/2008 | EP1499325B1 Composition comprising trehalose and zinc and use thereof to inhibit skin irritation |
07/16/2008 | EP1476541B1 Cytokine (zcytor17 ligand) |
07/16/2008 | EP1471907B1 Use of c-kit inhibitors for treating autoimmune diseases |
07/16/2008 | EP1446104B1 Spray drying methods |
07/16/2008 | EP1392264B1 Delivery of antiemetics through an inhalation route |
07/16/2008 | EP1392257B1 Delivery of antihistamines through an inhalation route |
07/16/2008 | EP1305006B1 Process for the manufacture of dispersions for formulating slightly or poorly soluble active ingredients |
07/16/2008 | EP1294367B1 Oral compositions comprising host-response modulating agent |
07/16/2008 | EP1265603B1 Il-8 receptor antagonists |
07/16/2008 | EP0951551B1 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
07/16/2008 | CN101223160A Benzoimidazole compound capable of inhibiting prostaglandin D synthetase |
07/16/2008 | CN101223153A Dibenzocycloheptane compounds and pharmaceuticals containingthese compounds |
07/16/2008 | CN101223147A Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
07/16/2008 | CN101223143A 3-cyanoquinoline inhibitors of TPL2 kinase and methods of making and using the same |
07/16/2008 | CN101222941A A method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNF alpha and a carrier protein |
07/16/2008 | CN101220089A Chinese South China sea signal conus neurotoxin gene Lt3.1 and uses thereof |
07/16/2008 | CN101219985A N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action |
07/16/2008 | CN101219202A Soup for strengthening tendon and waist |
07/16/2008 | CN101219198A Externally used drug for treating rheumatism orthopedic disorders |
07/16/2008 | CN101219180A Health care wine and its processing method |
07/16/2008 | CN101219178A Ointment |
07/16/2008 | CN101219177A Antalgica for neck and waist |
07/16/2008 | CN101219174A Medicine for treating rheumatic heart disease |
07/16/2008 | CN101219169A Externally used Chinese medicine for treating prostate gland hyperplasia and delaying human body caducity |
07/16/2008 | CN101219147A Dectancyl mastication tablet for dogs and cats |
07/16/2008 | CN101219145A Quinazoline derivatives as VEGF inhibitors |
07/16/2008 | CN101219131A Method for applying calcium polyenoic acid for medical and beauty treatment fields |
07/16/2008 | CN101219130A Compound pharmaceutical composition, preparation method and use of the same |
07/16/2008 | CN101219128A Dexibuprofen pharmaceutical composition with improved dissolving out capability and method for preparing the same |
07/16/2008 | CN101218983A Chinese medicinal herb cold tea |
07/16/2008 | CN101218954A Chinese cabbage ice cream |
07/16/2008 | CN101218951A Internal mixing loquat leaf and Sichuan fritillary bulb bonbon |
07/16/2008 | CN101218948A Health care beverage of edible burdock root |
07/16/2008 | CN100402643C 感染性克隆 Infectious clone |
07/16/2008 | CN100402543C Preparation method of hyperin and hypericin of Hypericum perforatum |
07/16/2008 | CN100402521C 4-imidazolin-2-one compounds |
07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
07/16/2008 | CN100402496C Compounds useful as matrix metalloprotease inhibitors |
07/16/2008 | CN100402085C Production of high-concentration thymic peptide solution and large-specification thymic peptide preparation |
07/16/2008 | CN100402079C Pain-relieving plaster and preparation method thereof |
07/16/2008 | CN100402067C External use medicine for treating rheumatosis and rheumatoid disease, and its preparation method |
07/16/2008 | CN100402040C Pain easing pharmaceutical composition and cataplasm thereof |
07/16/2008 | CN100402025C Modified release pharmaceutical formulation |
07/16/2008 | CN100402024C Gingko lactone freeze dried powder injection and its preparation method |
07/16/2008 | CN100402001C Methods and apparatus for improved administration of fentanyl and supentanil |
07/15/2008 | US7399878 Pharmaceutical compounds |
07/15/2008 | US7399829 Variants of RANKL protein |
07/15/2008 | US7399765 Substituted diazabicycloalkane derivatives |
07/15/2008 | US7399761 Phthalazine derivatives with angiogenesis inhibiting activity |
07/15/2008 | US7399583 Mixing the HuR protein and the ARE-containing mRNA in the presence of the candidate inhibitor and in the absence of the candidate inhibitor; detecting and comparing the amount of complexes with the non-complexed mRNA/protein species; identifying a candidate inhibitor |
07/15/2008 | US7399464 Polypeptides of the IFNα-7 gene |
07/15/2008 | US7399463 HSA-free formulations of interferon-beta |
07/15/2008 | CA2373296C Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders |
07/15/2008 | CA2290615C Desensitizing dentifrice having limited astringency |
07/15/2008 | CA2271857C Method for treating symptoms of diabetes |
07/15/2008 | CA2207103C Methods to identify hemochromatosis |
07/15/2008 | CA2205557C Monofunctional and/or polyfunctional polylysine conjugates |
07/15/2008 | CA2202503C Modified polyunsaturated fatty acids |
07/15/2008 | CA2113023C Tnf receptor promoter |
07/10/2008 | WO2008083160A2 Methods and compositions for therapeutic treatment |
07/10/2008 | WO2008082490A2 Novel jnk inhibitors |
07/10/2008 | WO2008082487A2 Novel jnk inhibitors |
07/10/2008 | WO2008081580A1 Analgesic agent comprising cyclic phosphatidic acid derivative |
07/10/2008 | WO2008080955A1 Isosorbide mononitrate derivatives for the treatment of intestinal disorders |
07/10/2008 | WO2008080939A1 Isosorbide mononitrate derivatives for the treatment of ocular hypertension |
07/10/2008 | WO2008080461A1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists |
07/10/2008 | WO2008080218A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
07/10/2008 | WO2008080194A1 Pain-relieving compositions and uses therefor |
07/10/2008 | WO2008052072A9 Compounds for the treatment of pain and screening methods therefor |
07/10/2008 | WO2002072778A3 Method for identifying inhibitors of g protein coupled receptor signaling |
07/10/2008 | US20080167388 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
07/10/2008 | US20080167377 Novel compounds |
07/10/2008 | US20080167376 Methods and products which utilize N-acyl-L-aspartic acid |
07/10/2008 | US20080167362 Time-release tablets or capsules also containing an opoid or analgesic; cyclooxygenase-2 inhibitors |
07/10/2008 | US20080167338 Compounds and methods for kinase modulation, and indications therefor |
07/10/2008 | US20080167334 Modulators of estrogen receptor alpha/beta G protein-coupled receptor 30, e.g., 1-(4-(6-Bromo-benzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)1-ethanone; treating diseases such as cancer, neurodegenerative disorders, obesity, osteoporosis, and symptoms of menopause |
07/10/2008 | US20080167332 Novel Compounds 243 |
07/10/2008 | US20080167315 Analgesics; potassium channel moderators; headaches; antiepileptic agents; psychological disorders; incontinence; neuropathic pain |
07/10/2008 | US20080167314 Condensed Imidazole Compound And Use Thereof |
07/10/2008 | US20080167289 Pyrimidinohydrodiazepinones, e.g., 2-(1,6-dihydro-4-methyl-6-oxopyridin-3-ylamino)-9-cyclopentyl-8,9-dihydro-5,7,7-trimethyl-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one; especially c-Met kinase inhibitors; anticancer agents |
07/10/2008 | US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases |
07/10/2008 | US20080167287 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
07/10/2008 | US20080167257 Therapy of acroparaesthsia, allergic (psoric) conditions, allergic reactions, alopecia, amnesia, anaphrodisia, angina, arthritis, asthenopia, biliary sycosis, burns, cancerous conditions, such as colon cancer, malignant melanoma and malignant nasal polyps, carpal tunnel syndrome, colds, conjunctivitis |
07/10/2008 | US20080167253 Antiinflammatory agents; antiarthritic agents; antiscarring agents; isolated oligopeptide which can be obtained from the microorganism Entamoeba histolytica or synthesized |
07/10/2008 | US20080167249 Protective factors against inflammation, burns and noxious stimuli |
07/10/2008 | US20080167228 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
07/10/2008 | US20080167227 biodrug laminin protein as angiogenesis inhibitors, antitumor agents; Inducing apoptosis in tissues; binding antibodies |
07/10/2008 | US20080167223 Methods and Compositions for Using Tsh in the Inhibition of Tnf Activity |
07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |